Ranalexin

155761-99-2

L-Cysteine, L-phenylalanyl-L-leucylglycylglycyl-L-leucyl-L-isoleucyl-L-lysyl-L-isoleucyl-L-valyl-L-prolyl-L-alanyl-L-methionyl-L-isoleucyl-L-cysteinyl-L-alanyl-L-valyl-L-threonyl-L-lysyl-L-lysyl-, cyclic (14→20)-disulfide; 1,2-Dithia-5,8,11,14,17,20-hexaazacyclotricosane, cyclic peptide deriv; (4R,7S,10S,13S,16S,19S,22R)-22-((2S,3S)-2-((S)-2-((S)-2-((S)-1-(L-phenylalanyl-L-leucylglycylglycyl-L-leucyl-L-isoleucyl-L-lysyl-L-isoleucyl-L-valyl)pyrrolidine-2-carboxamido)propanamido)-4-(methylthio)butanamido)-3-methylpentanamido)-7,10-bis(4-aminobutyl)-13-((R)-1-hydroxyethyl)-16-isopropyl-19-methyl-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxylic Acid;